BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21611153)

  • 1. Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.
    Jones MR; Chua A; Chen YD; Li X; Krauss RM; Rotter JI; Legro RS; Azziz R; Goodarzi MO
    PLoS One; 2011; 6(5):e20120. PubMed ID: 21611153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.
    Goodarzi MO; Maher JF; Cui J; Guo X; Taylor KD; Azziz R
    Hum Reprod; 2008 Dec; 23(12):2842-9. PubMed ID: 18757445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
    Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
    Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome.
    Almawi WY; Gammoh E; Malalla ZH; Al-Madhi SA
    PLoS One; 2016; 11(11):e0165636. PubMed ID: 27846231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
    Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
    Goodarzi MO; Louwers YV; Taylor KD; Jones MR; Cui J; Kwon S; Chen YD; Guo X; Stolk L; Uitterlinden AG; Laven JS; Azziz R
    Fertil Steril; 2011 Apr; 95(5):1736-41.e1-11. PubMed ID: 21300347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.
    Jones MR; Chazenbalk G; Xu N; Chua AK; Eigler T; Mengesha E; Chen YH; Lee JM; Pall M; Li X; Chen YD; Taylor KD; Mathur R; Krauss RM; Rotter JI; Legro RS; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1750-7. PubMed ID: 22723319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family-based analysis of candidate genes for polycystic ovary syndrome.
    Ewens KG; Stewart DR; Ankener W; Urbanek M; McAllister JM; Chen C; Baig KM; Parker SC; Margulies EH; Legro RS; Dunaif A; Strauss JF; Spielman RS
    J Clin Endocrinol Metab; 2010 May; 95(5):2306-15. PubMed ID: 20200332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).
    Ben-Salem A; Ajina M; Suissi M; Daher HS; Almawi WY; Mahjoub T
    Gene; 2014 Jan; 533(2):554-7. PubMed ID: 24157263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating leptin concentration, LEP gene variants and haplotypes, and polycystic ovary syndrome in Bahraini and Tunisian Arab women.
    Dallel M; Sghaier I; Finan RR; Douma Z; Hachani F; Letaifa DB; Mahjoub T; Almawi WY
    Gene; 2019 Apr; 694():19-25. PubMed ID: 30721746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.
    Ben Salem A; Megdich F; Kacem O; Souayeh M; Hachani Ben Ali F; Hizem S; Janhai F; Ajina M; Abu-Elmagd M; Assidi M; Al Qahtani MH; Mahjoub T
    BMC Genomics; 2016 Oct; 17(Suppl 9):748. PubMed ID: 27766947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
    Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
    Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
    Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.
    Goodarzi MO; Xu N; Cui J; Guo X; Chen YI; Azziz R
    Hum Reprod; 2008 May; 23(5):1214-9. PubMed ID: 18332089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome.
    Klenke S; Tan S; Hahn S; Mann K; Hauner H; Manthey I; Peters J; Siffert W; Frey UH
    Pharmacogenet Genomics; 2010 Aug; 20(8):476-84. PubMed ID: 20562673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
    Goodarzi MO; Antoine HJ; Azziz R
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
    Yilmaz M; Yurtçu E; Demirci H; Ergün MA; Ersoy R; Karakoç A; Yetkin I; Cakir N; Ayvaz G; Arslan M
    J Endocrinol Invest; 2009 Jan; 32(1):13-7. PubMed ID: 19337008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
    Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
    Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
    Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.